HbA1c Testing Companies
The market for HbA1c testing, which is used for the long-term management of diabetes, was primarily dominated by a few key players, each known for their innovative testing solutions.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Latest HbA1c testing Companies Update
-
July 2023: Assure PT Care PT/INR Monitoring System is now available thanks to a strategic partnership between ARKRAY USA, Inc. and CoaguSense, Inc., a leader in diabetes and resident care solutions for long-term care institutions. Using a unique micromechanical mechanism, the Assure PT Care point-of-care test can produce outcomes identical to those of the industry-recognized WHO tilt-tube method. The exclusive distributor of this item is ARKRAY USA. Results are reported in PT seconds and INR with gold-standard accuracy and precision. Monitoring patients on anticoagulant therapy requires timely results for the best possible care options. The wireless, personable, and compact technology will improve the operational efficacy of PT/INR testing and provide speedy results for prompt treatment options. In a CLIA-waived facility, Assure PT Care is approved for usage by professionals.
-
Feb 2023: The new public company that Danaher intends to launch in the fourth quarter of 2023 will be known as Veralto Corporation, the Danaher Corporation announced. Veralto, a remarkable collection of industry-leading brands in Danaher's Environmental and Applied Solutions (EAS) division, will include Hach, Trojan, OTT HydroMet, ChemTreat, and McCrometer from its Water Quality Platform and Videojet, Esko, X-Rite Pantone, and Linx from its Product Identification Platform. In 2022, the EAS company generated over $4.8 billion in revenue and employed 16,000 people worldwide. As a stand-alone corporation, Veralto is predicted to receive an investment-grade credit rating.
List of HbA1c testing Key companies in the market
- Bio-Rad Laboratories, Inc. (US)
- Abbott Laboratories (US)
- ARKRAY, Inc. (Japan)
- Danaher Corporation (US)
- Hoffmann-La Roche Ltd (Switzerland)
- Transasia Bio-Medicals (India)
- Siemens Healthineers (US)
- EKF Diagnostics (UK)
- PTS Diagnostics (US)
- Agappe Diagnostics Ltd (India)
- Trinity Biotech PLC (Ireland)
- DiaSys Diagnostic Systems GmbH (Germany)
- CPC Diagnostics Pvt. Ltd. (India)
- Tosoh India Pvt. Ltd (India)
- Rapid Diagnostics Group of Companies (India)
HbA1c Testing Market Highlights:
HbA1c Testing Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
